tubercidin has been researched along with Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, R; Drachman, DB; Kuncl, RW; Lehar, M | 1 |
| Adams, RN; Avila, O; DeSilva, S; Kuncl, RW; Lehar, M; Lucas, D; McIntosh, K; Pestronk, A; Wiggins, WW; Wittstein, I | 1 |
2 other study(ies) available for tubercidin and Myasthenia Gravis
| Article | Year |
|---|---|
3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
Topics: Animals; Cells, Cultured; Depression, Chemical; Endocytosis; In Vitro Techniques; Kinetics; Methylation; Muscle Proteins; Muscles; Myasthenia Gravis; Rats; Receptors, Cholinergic; Tubercidin | 1993 |
A novel therapy for myasthenia gravis by reducing the endocytosis of acetylcholine receptors.
Topics: Animals; Down-Regulation; Endocytosis; Female; Immunization; Immunization, Passive; Mice; Myasthenia Gravis; Rats; Rats, Inbred Lew; Receptors, Nicotinic; Tubercidin | 1993 |